Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA grants fast track designation for GSK Neisseria gonorrhoeae investigational vaccine

Ruchika Sharma27 Jun 2023 1:30 PM IST

Gonorrhoea is a sexually transmitted infection caused by a bacterium called Neisseria gonorrhoeae.

Japan approves GSK shingles vaccine Shingrix for at risk adults aged 18 and over

Ruchika Sharma27 Jun 2023 12:30 PM IST

London: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved an updated indication for Shingrix...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb bags European Commission nod for heart disease treatment Camzyos

Ruchika Sharma27 Jun 2023 11:31 AM IST

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved CAMZYOS (mavacamten, 2.5 mg, 5 mg, 10 mg,...

AstraZeneca former Chief Gagandeep Singh joins Boehringer Ingelheim as MD, Head of Human Pharma India

Ruchika Sharma26 Jun 2023 5:12 PM IST

Gagandeep Singh joins Boehringer Ingelheim from AstraZeneca, where he was the Managing Director for India and Africa Cluster Head.

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca Soliris recommended for nod in EU by CHMP for children, adolescents with refractory generalised myasthenia gravis

Ruchika Sharma26 Jun 2023 4:37 PM IST

Soliris is a first-in-class C5 complement inhibitor.

Fortis to onboard new 550-bed super specialty hospital in Lucknow

Fortis Healthcare fund diversion case: Sebi issues demand notices to 5 entities

Ruchika Sharma26 Jun 2023 2:30 PM IST

The five entities that received notices are Saubhagya Buildcon, Zolton Properties, Tiger Developers, Torus Buildcon and Rosestar Marketing.

Govt kept same rules for foreign, Indian firms while COVID vaccines procurement: Dr Mansukh Mandaviya

Ruchika Sharma26 Jun 2023 1:30 PM IST

"If our own companies are not seeking such relaxations and following our rules and regulations, then it is natural that global companies also do the...

Dr Jitendra Singh unveils Omicron specific mRNA based Booster vaccine "GEMCOVAC -OM"

Ruchika Sharma26 Jun 2023 12:30 PM IST

GEMCOVAC -OM is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA- based vaccines.

Ajanta Pharma Sets Up Wholly Owned Subsidiary in Ireland

Ajanta Pharma Dahej facility concludes USFDA inspection with no Form 483

Ruchika Sharma26 Jun 2023 11:08 AM IST

Mumbai: Ajanta Pharma has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection at the Company's Dahej...

Govt mulling to divest stake in 2 pharma units, says Union Health Minister

Ruchika Sharma25 Jun 2023 3:30 PM IST

Mandaviya did not name any company which the government plans to divest or share any other details on the stage at which the proposals are at present.

HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit

Kite announces completion of marketing authorization transfer for Yescarta CAR T-cell therapy in Japan

Ruchika Sharma25 Jun 2023 2:30 PM IST

Santa Monica: Kite Pharma, Inc., a Gilead Company, has announced that the Marketing Authorization in Japan for Yescarta (axicabtagene...

Moderna seeks USFDA nod for updated COVID vaccine

Ruchika Sharma25 Jun 2023 11:45 AM IST

Cambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that it has completed...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok